Sign in

CIK 0001348362

  • Non-accelerated filer
  • Smaller reporting company

Lexaria Bioscience Corp.

Sign in to watch
Ticker
LEXX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Aug 31
Incorporated
NV
Entity type
Operating
EIN
202000871
Phone
+1 250-765-6424
Business address
100 - 740 MCCURDY ROAD, KELOWNA, British Columbia, Canada, V1X 2P7
Former names
Lexaria Corp., LEXARIA CORP.
  1. 4 Open-market buy Chairman/CEO/President bought 3,000 shares at $0.37 ($1,095)
  2. 4 Open-market buy Chairman/CEO/President bought 11,000 shares at an average $0.35 ($3,845)
  3. 4 Open-market buy Chairman/CEO/President bought 15,500 shares at an average $0.30 ($4,720)
  4. 4 Open-market buy Chairman/CEO/President bought 4,000 shares at $0.34 ($1,360)
  5. 4 Open-market buy Chairman/CEO/President bought 4,500 shares at an average $0.32 ($1,440)
  6. 4 Open-market buy Chairman/CEO/President bought 8,500 shares at an average $0.33 ($2,767)
  7. 4 Open-market buy Chairman/CEO/President bought 5,000 shares at an average $0.34 ($1,688)
  8. 4 Open-market buy Chairman/CEO/President bought 20,088 shares at an average $0.31 ($6,176)
  9. 4 Open-market buy Chairman/CEO/President bought 110,000 shares at an average $0.21 ($23,000)
  10. 4 Insider Changes in Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 16 of 21 · 420 filings